ADAM9 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.575800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.809200E-01
Normal-vs-Stage2
3.836600E-01
Normal-vs-Stage3
6.419800E-01
Normal-vs-Stage4
2.874400E-01
Stage1-vs-Stage2
2.308800E-01
Stage1-vs-Stage3
5.516200E-01
Stage1-vs-Stage4
1.335360E-01
Stage2-vs-Stage3
6.875400E-01
Stage2-vs-Stage4
1.811800E-01
Stage3-vs-Stage4
3.595400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.928800E-01
Normal-vs-AfricanAmerican
4.497600E-01
Normal-vs-Asian
4.611200E-01
Caucasian-vs-AfricanAmerican
9.194600E-01
Caucasian-vs-Asian
9.689200E-01
AfricanAmerican-vs-Asian
9.445800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.845200E-01
Normal-vs-Female
4.314400E-01
Male-vs-Female
8.122600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.183000E-01
Normal-vs-Age(41-60Yrs)
2.619400E-01
Normal-vs-Age(61-80Yrs)
5.567200E-01
Normal-vs-Age(81-100Yrs)
7.535800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.150200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.576400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.809400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.379600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.503820E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.792200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.164600E-01
Normal-vs-Daily Drinker
7.833800E-01
Normal-vs-Weekly Drinker
5.309200E-01
Normal-vs-Occasional Drinker
3.074800E-01
Normal-vs-Social Drinker
6.949800E-01
Non Drinker-vs-Daily Drinker
3.252800E-01
Non Drinker-vs-Weekly Drinker
9.712600E-01
Non Drinker-vs-Occasional Drinker
2.515200E-01
Non Drinker-vs-Social Drinker
6.799800E-01
Daily Drinker-vs-Weekly Drinker
4.094200E-01
Daily Drinker-vs-Occasional Drinker
5.387500E-02
Daily Drinker-vs-Social Drinker
6.880600E-01
Weekly Drinker-vs-Occasional Drinker
3.338000E-01
Weekly Drinker-vs-Social Drinker
7.462800E-01
Occasional Drinker-vs-Social Drinker
2.105400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.547600E-01
Normal-vs-Grade 2
5.730100E-02
Normal-vs-Grade 3
4.558200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.539700E-03
Grade 1-vs-Grade 3
3.177000E-04
Grade 1-vs-Grade 4
2.547600E-01
Grade 2-vs-Grade 3
8.350000E-02
Grade 2-vs-Grade 4
5.730100E-02
Grade 3-vs-Grade 4
4.558200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.180600E-01
Normal-vs-NonDiabetic
4.216400E-01
Diabetic-vs-NonDiabetic
1.791370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.385400E-01
Normal-vs-NoPancreatitis
4.655400E-01
Pancreatitis-vs-NoPancreatitis
6.240500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.056800E-01
Normal-vs-N1
3.848200E-01
N0-vs-N1
2.130200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.671210E-01
Normal-vs-TP53-NonMutant
9.621000E-01
TP53-Mutant-vs-TP53-NonMutant
3.68339999945455E-07
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
